就公司审计委员会而言，独立非执行董事任为先生将辞去成员职务，而独立非执行董事Marina S. Bozilenko女士将获委任为成员。经上述变动后，审计委员会将由叶长青先生(主席)、吕大忠博士及Marina S. Bozilenko女士组成。ASCENTAGE-B (06855) announced that Marc E. Lippman, MD has been appointed as the company...
According to Zhito Finance APP, ASCENTAGE-B (06855) announced the appointment of Marc E. Lippman, MD as an additional independent non-executive Director, effective from January 2, 2025.
Regarding the nomination committee, Chairman and Executive Director Dr. Yang Dajun will resign from the chairmanship, independent non-executive Director Dr. David Sidransky will be appointed as Chairman, and independent non-executive Director Marc E. Lippman, MD will be appointed as a member. After these changes, the nomination committee will consist of Dr. David Sidransky (Chairman), Mr. Ren Wei, and Marc E. Lippman, MD.
Regarding the company's audit committee, independent non-executive Director Mr. Ren Wei will resign as a member, while independent non-executive Director Ms. Marina S. Bozilenko will be appointed as a member. After these changes, the audit committee will be composed of Mr. Ye Changqing (Chairman), Dr. Lv Dazhong, and Ms. Marina S. Bozilenko.
Regarding the company's remuneration committee, Chairman and Executive Director Dr. Yang Dajun will resign as a member, and independent non-executive Director Dr. Debra Yu will be appointed as a member. After these changes, the remuneration committee will be composed of Mr. Ren Wei (Chairman), Mr. Ye Changqing, and Dr. Debra Yu.
